Exploring the potential of Carica Papaya Leaf Extract: a perspective on its effectiveness in ameliorating thrombocytopenia in dengue patients

Background: Dengue fever (DF) is endemic in Pakistan, posing health risks. Recent flooding in 2022 and strong monsoon rains in 2024 have increased the possibility of an epidemic. It is an infectious disease having potentially severe outcomes including thrombocytopenia.Discussion: Carica Papaya Leaf...

Full description

Saved in:
Bibliographic Details
Main Authors: Maliha Khalid, Muhammad Saad Khan, Erum Siddiqui, Aminath Waafira
Format: Article
Language:English
Published: Taylor & Francis Group 2025-12-01
Series:Infection Ecology & Epidemiology
Subjects:
Online Access:https://www.tandfonline.com/doi/10.1080/20008686.2025.2456055
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Background: Dengue fever (DF) is endemic in Pakistan, posing health risks. Recent flooding in 2022 and strong monsoon rains in 2024 have increased the possibility of an epidemic. It is an infectious disease having potentially severe outcomes including thrombocytopenia.Discussion: Carica Papaya Leaf Extract (CPLE) has emerged as an off-label treatment option, showing promising results in increasing platelet counts and reducing hospital stays. However, a critical assessment of existing research reveals methodological flaws, hindering specific recommendations.Conclusion: This perspective advocates for comprehensive research to evaluate the risks and benefits of CPLE as a potential remedy for thrombocytopenia associated with dengue fever. A robust investigation will inform clinical practice and guide healthcare decisions, contributing to improved patient outcomes in dengue-endemic areas.
ISSN:2000-8686